Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer

SUPPLEMENTARY MATERIALS AND METHODS
Characterization of the two anti-phosphorylated NPM1 antibodies
Silencing of NPM1 was performed by siRNA experiment as previously described (Destouches et al., 2011) .
For alkaline phosphatase treatment, LNCaP cells were starved for 24 hours and then stimulated with 10 nmol/L DHT for 1 hour. Cells were fixed with methanol for 10 minutes at -20°C, air-dried, and re-hydrated in PBS for 10 minutes at room temperature. Cells were incubated in 100 mM glycine, pH 10.4, containing 10 units of alkaline phosphatase type IV (Sigma) for 2 hours at 37°C. The control cells were incubated in the solution without alkaline phosphatase. Cells were washed two times with
